Skip to content

Clinical trials

Withdrawn Phase 3 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 3 Status: Withdrawn Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20082
20132
20151
20161
20185
20201
20211
20222
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology2
AstraZeneca2
Atossa Therapeutics, Inc.1
Centre Leon Berard1
Danish Breast Cancer Cooperative Group1
ETOP IBCSG Partners Foundation1
EirGenix, Inc.1
EndoCeutics Inc.1
Eurofarma Laboratorios S.A.1
Health Clinics Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms25
Neoplasm Metastasis3
Atrophic Vaginitis1
Brain Neoplasms1
Breast Carcinoma In Situ1
Carcinoma, Intraductal, Noninfiltrating1
Carcinoma, Non-Small-Cell Lung1
Colonic Neoplasms1
Esthesioneuroblastoma, Olfactory1
Head and Neck Neoplasms1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.